With many countries, especially in Europe, experiencing a second wave of the pandemic, the need for a Covid-19 vaccine is being increasingly felt. Also, America’s Pfizer Inc and Germany’s BioNTech SE have applied for emergency use authorisation in the United States for their joint vaccine candidate. Hyderabad-based Bharat Biotech, whose vaccine candidate is called Covaxin, said in a statement to Mint that interested volunteers staying near the trial site can meet the principal investigator for participating in the trial. Bharat Biotech began phase three trials of Covaxin earlier this week in what is the largest efficacy trial ever in India. The company is also in touch with Brazil, the world’s third worst-hit country, to offer the South American nation its vaccine candidate, executive director Sai Prasad told Reuters.

Source: Hindustan Times November 21, 2020 02:43 UTC